294 related articles for article (PubMed ID: 26933996)
1. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
[TBL] [Abstract][Full Text] [Related]
2. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
3. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
4. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
5. Serum sphingosine 1-phosphate in hepatocellular carcinoma patients is related to HBV infection.
Dong H; Xiao J; Zhu R; Liu B; Dong M; Luo D; Sun T; Li Q; Jin J
J BUON; 2018; 23(6):1711-1716. PubMed ID: 30610798
[TBL] [Abstract][Full Text] [Related]
6. Serum sphingosine negatively correlates with albumin predicting the risk of hepatocellular carcinoma.
Huang K; Li W; Xiao J; Luo D; Jin J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):203-208. PubMed ID: 31074463
[TBL] [Abstract][Full Text] [Related]
7. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.
Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894
[TBL] [Abstract][Full Text] [Related]
8. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
9. Elevated Plasma Ceramides Are Associated With Higher White Matter Hyperintensity Volume-Brief Report.
Mielke MM; Syrjanen JA; Bui HH; Petersen RC; Knopman DS; Jack CR; Graff-Radford J; Vemuri P
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2431-2436. PubMed ID: 31510790
[TBL] [Abstract][Full Text] [Related]
10. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
11. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
[TBL] [Abstract][Full Text] [Related]
12. The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma.
Qiu F; Qiu F; Liu L; Liu J; Xu J; Huang X
Genet Test Mol Biomarkers; 2018 Apr; 22(4):218-223. PubMed ID: 29641283
[TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
14. Preanalytical Biases in the Measurement of Human Blood Sphingolipids.
Brunkhorst R; Pfeilschifter W; Patyna S; Büttner S; Eckes T; Trautmann S; Thomas D; Pfeilschifter J; Koch A
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735920
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
17. Plasma sphingolipids and lung cancer: a population-based, nested case-control study.
Alberg AJ; Armeson K; Pierce JS; Bielawski J; Bielawska A; Visvanathan K; Hill EG; Ogretmen B
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1374-82. PubMed ID: 23749868
[TBL] [Abstract][Full Text] [Related]
18. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
19. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
20. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
Becker S; Kinny-Köster B; Bartels M; Scholz M; Seehofer D; Berg T; Engelmann C; Thiery J; Ceglarek U; Kaiser T
PLoS One; 2017; 12(3):e0174424. PubMed ID: 28334008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
